11 October 2018 in IEEE Journal of Solid-State Circuits
The advancement of implantable medical devices for the treatment of neurological disorders demands energy-efficient, low-latency processors for responsive, safe, and personalized neuromodulation. A 130-nm CMOS neural interface processor is presented to perform the brain-state classification and closed-loop control using programmable-waveform electrical stimulation. The architecture features an autoencoder neural network for both spatial filtering and dimensionality reduction. Dedicated feature extraction blocks are implemented for univariate (signal-band energy) and multivariate (phase locking value, and cross-frequency coupling) neural signal processing. The proceeding exponentially decaying memory support vector machine (EDM-SVM) accelerator employs these features for hardware-efficient brain-state classification with a high temporal resolution. An integrated digitally charge-balanced waveform generator enables flexibility in finding optimal neuromodulation paradigms for pathological symptom suppression. The system on chip (SoC) is validated using the EU human intracranial electroencephalography epilepsy data set, achieving a seizure sensitivity of 97.7% and a false detection rate of 0.185/h while consuming 169 $\mu \text{J}$ per classification.
13 November 2023 in IEEE Transactions on Biomedical Circuits and Systems
This paper presents an innovative, minimally invasive, battery-free, wireless, peripheral nervous system (PNS) neural interface, which seamlessly integrates a millimeter-scale, fascicle-selective integrated circuit (IC) with extraneural recording and stimulating channels. The system also incorporates a wearable interrogator equipped with integrated machine-learning capabilities. This PNS interface is specifically tailored for adaptive neuromodulation therapy, targeting individuals with paralysis, amputation, or chronic medical conditions. By employing a neural pathway classifier and temporal interference stimulation, the proposed interface achieves precise deep fascicle selectivity for recording and stimulation without the need for nerve penetration or compression. Ultrasonic energy harvesters facilitate wireless power harvesting and data reception, enhancing the usability of the system. Key circuit performance metrics encompass a 2.2 μVrms input-referred noise, 14-bit ENOB, and a 173 dB Schreier figure of merit (FOM) for the neural analog-to-digital converter (ADC). Additionally, the ultra-low-power radio-frequency (RF) transmitter boasts a remarkable 1.38 pJ/bit energy efficiency. In vivo experiments conducted on rat sciatic nerves provide compelling evidence of the interface's ability to selectively stimulate and record neural fascicles. The proposed PNS neural interface offers alternative treatment options for diagnosing and treating neurological disorders, as well as restoring or repairing neural functions, improving the quality of life for patients with neurological and sensory deficits.
14 November 2022 in bioRxiv
Bioelectronic interfaces have the potential to revolutionize the treatment of medical disorders and augment physiology. Implantable devices such as pacemakers and deep brain stimulators have already been deployed to control activity in diseases including Parkinson’s disease and epilepsy. These devices typically operate by delivering electrical stimulation at pre-programmed intervals (known as open-loop stimulation). Recent advances in machine learning and low-power integrated circuits have led to the emergence of personalized medical devices that monitor the user’s state and stimulate in response to measured biological activity (known as closed-loop stimulation). There are two key questions that require fundamental research to achieve breakthroughs in personalized devices: 1) What biomarkers and algorithms are best suited to detecting biological states (e.g. seizures in epilepsy)? and 2) What types of electrical stimuli are optimal for controlling these states? The answer to these questions can be explored in vitro using multielectrode array (MEA) systems that interface with biological tissue with reduced experimental complexity, better reproducibility, and fewer confounding variables present in whole organisms. However, existing MEA systems have functional limitations and closed-source designs that prevent researchers from developing improvements. This paper introduces OpenMEA, an open-source platform for closed-loop bioelectronics research. OpenMEA includes designs for the components necessary to build a benchtop in vitro laboratory, including electrophysiological recording and stimulation electronics, a microfluidic perfusion system, and physical designs for multielectrode arrays. The system is demonstrated with the electrical recording and stimulation of epileptogenic human and rodent brain slices. The aim of OpenMEA is to democratize bioelectronic research tools to accelerate the deployment of devices for the treatment of disorders and beyond.
16 October 2024 in IEEE Transactions on Biomedical Circuits and Systems
Personalized brain implants have the potential to revolutionize the treatment of neurological disorders and augment cognition. Medical implants that deliver therapeutic stimulation in response to detected seizures have already been deployed for the treatment of epilepsy. These devices require low-power integrated circuits for life-long operation. This constraint impedes the integration of machine-learning driven classifiers that could improve treatment outcomes. This paper introduces BrainForest, a neuromorphic multiplier-less bit-serial weight-memory-optimized brain-state classification processor. The architecture achieves state-of-the-art energy efficiency using two layers of neuron models to implement the spectral and temporal functions needed for classification: 1) resonate-and-fire neurons are used to extract physiological signal band energy EEG biomarkers 2) leaky integrator neurons are used to build multi-timescale representations for classification. Sparse neural model firing activity is used to clock-gate device logic, thereby decreasing power consumption by 93%. An energy-optimized 1024-tree boosted decision forest performs the classification used to trigger stimulation in response to detected pathological brain states. The IC is implemented in 65nm CMOS with state-of-the-art power consumption (best case: 9.6μW, typical: 118μW), achieving a seizure sensitivity of 97.5% with a false detection rate of 2.08 per hour.
1 July 2017 in 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
Growing evidence suggests that cross-frequency coupling (CFC) is a key mechanism in neuronal computation, communication, and learning in the brain. Abnormal CFC has been implicated in pathological brain states such as epilepsy and Parkinson's disease. A reduction in excessive coupling has been shown in effective neuromodulation treatments, suggesting that CFC may be a useful feedback measure in closed-loop neural stimulation devices. However, processing latency limits the responsiveness of such systems. A VLSI architecture is presented which implements three selectable measures of CFC to enable the application specific trade-off between low-latency and high-accuracy processing. The architecture is demonstrated using in-vitro human neocortical slice recordings, with a latency of 48ms.